TD Capital Management’s Avidity Biosciences RNAM Stock Holding History

TD Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10	Closed	-$721	–	907
2025 Q4	$721	Hold	10	–	–	﹤0.01%	684
2025 Q3	$436	Hold	10	–	–	﹤0.01%	661
2025 Q2	$284	Hold	10	–	–	﹤0.01%	679
2025 Q1	$295	Buy	+10	New	+$311	﹤0.01%	637

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

TD Capital Management's RNAM Position: Q1 2026 in Review

TD Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 10 shares — an estimated $721 sold.

TD Capital Management first reported a position in RNAM in Q1 2025 and held it in 4 quarters. The position peaked at $721 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

TD Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
TD Capital Management sold 10 Avidity Biosciences shares in Q1 2026, an estimated $721.
TD Capital Management first reported a position in Avidity Biosciences in Q1 2025 and held it in 4 quarters.
TD Capital Management's Avidity Biosciences position peaked at $721 in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.